MedTrace Logo

ChemoFx® PRO - A Post-Market Data Collection Study

NCT00669422 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2756

Last updated 2012-10-05

No results posted yet for this study

Summary

This study will collect patient demographic, oncology history, and physician reported outcome information following the initial round of chemotherapy received after a commercial ChemoFx® Final Report for the generation of hypotheses of potential patient cohorts for further sub-studies.

Conditions

Sponsors & Collaborators

  • Precision Therapeutics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00669422 on ClinicalTrials.gov